Jeffery Kutok

Insider Reports History

Location
Cambridge, MA
Signature
/s/ John Weidenbruch, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffery Kutok:

Company Role Class Num Shares Value Price $ Report Date Ownership
Epizyme, Inc. Chief Scientific Officer Common Stock, par value $0.0001 0 $1.41 12 Aug 2022 Direct
Epizyme, Inc. Chief Scientific Officer Stock Option (Right to Buy) 0 $0.5600 09 Aug 2022 Direct

Insider Reports Filed by Jeffery Kutok

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000089924322028857-kutok-jeffery-2022-08-12 Epizyme, Inc. 12 Aug 2022 2 $0 4 Chief Scientific Officer 16 Aug 2022, 18:54
/report/000089924322028417-kutok-jeffery-2022-08-09 Epizyme, Inc. 09 Aug 2022 3 +$35,451 4 Chief Scientific Officer 11 Aug 2022, 20:52
/report/000089924322014724-kutok-jeffery-2022-04-11 Epizyme, Inc. 11 Apr 2022 1 -$2,467 4 Chief Scientific Officer 13 Apr 2022, 17:49
/report/000089924322011727-kutok-jeffery-2022-03-17 Epizyme, Inc. 17 Mar 2022 1 $0 4 Chief Scientific Officer 21 Mar 2022, 18:05
/report/000089924322004827-kutok-jeffery-2022-02-02 Epizyme, Inc. 02 Feb 2022 1 -$3,502 4 Chief Scientific Officer 04 Feb 2022, 15:15
/report/000089924321033406-kutok-jeffery-2021-08-16 Epizyme, Inc. 16 Aug 2021 2 $0 4 Chief Scientific Officer 18 Aug 2021, 08:09